التفاصيل البيبلوغرافية
| العنوان: |
Systemic Therapy for Hereditary Breast Cancers |
| المؤلفون: |
Harvey-Jones, Elizabeth J., Lord, Christopher J., Tutt, Andrew N.J. |
| المصدر: |
Hematology/Oncology Clinics of North America; February 2023, Vol. 37 Issue: 1 p203-224, 22p |
| مستخلص: |
Approximately 5% to 10% of all breast cancers are hereditary; many of which are caused by pathogenic variants in genes required for homologous recombination, including BRCA1and BRCA2. Here we discuss systemic treatment for such breast cancers, including approved chemotherapeutic approaches and also targeted treatment approaches using poly-(ADP ribose) polymerase inhibitors. We also discuss experimental approaches to treating hereditary breast cancer, including new small molecule DNA repair inhibitors and also immunomodulatory agents. Finally, we discuss how drug resistance emerges in patients with hereditary breast cancer, how this might be delayed or prevented, and how biomarker-adapted treatment is molding the future management of hereditary breast cancer. |
| قاعدة البيانات: |
Supplemental Index |
Full Text via ClinicalKey 
Full Text Finder